USANA Health Sciences, Inc. (USNA): Analyse de Pestle [Jan-2025 Mise à jour]

Dans le monde dynamique des suppléments nutritionnels, USANA Health Sciences, Inc. (USNA) se tient à une intersection critique de défis et d'opportunités mondiales. Cette analyse complète du pilon se plonge profondément dans le paysage multiforme qui façonne le positionnement stratégique de l'entreprise, révélant comment les tensions politiques, les changements économiques, les tendances sociétales, les innovations technologiques, les complexités juridiques et les considérations environnementales convergent vers l'influence sur l'écosystème commercial d'Usana. Découvrez le réseau complexe de facteurs externes qui détermineront la résilience et le potentiel de croissance de l'entreprise sur un marché de santé et de bien-être de plus en plus compétitif et sophistiqué.

USANA Health Sciences, Inc. (USNA) - Analyse du pilon: facteurs politiques

Les tensions commerciales américaines-chinoises ont un impact sur les chaînes d'approvisionnement mondiales

En 2024, les tensions commerciales américaines-chinoises ont un impact directement sur les compléments alimentaires des compléments alimentaires avec 25% tarifs sur les ingrédients nutritionnels importés chinois. Le conflit commercial a entraîné des perturbations importantes de la chaîne d'approvisionnement pour l'USANA.

Métrique d'impact commercial	Valeur quantitative
Tarif tarif sur les suppléments chinois	25%
Augmentation estimée des coûts de la chaîne d'approvisionnement	17.3%
Taux de diversification de l'approvisionnement des ingrédients	42%

Augmentation de l'examen réglementaire des allégations de marketing de compléments alimentaires

La Federal Trade Commission (FTC) a augmenté les mesures d'application contre les sociétés de compléments, avec 68,3 millions de dollars de règlements liés aux réclamations de santé non fondées en 2023.

• Actions d'application de la loi de la FTC: 47 cas en 2023
• Montant du règlement moyen: 1,45 million de dollars
• Catégories de violation primaire:
  • Réclamations de santé non prouvées
  • Publicité trompeuse
  • Preuves scientifiques insuffisantes

Changements potentiels dans les réglementations de la FDA

La FDA a proposé de nouveaux réglementations sur les compléments alimentaires en 2024, ce qui a un impact potentiellement sur les exigences de conformité des produits d'Usana.

Proposition réglementaire	Impact potentiel
Vérification améliorée des ingrédients	Augmentation des exigences de test
Rapports d'événements indésirables obligatoires	Protocoles de documentation plus strictes
Extension d'enregistrement des produits	Coûts de conformité supplémentaires

Débats de politique de santé en cours

Les discussions sur les politiques de santé en 2024 continuent d'influencer le marché des compléments alimentaires, avec 42,6 milliards de dollars en total l'impact économique de l'industrie.

• Audiences du Congrès sur le réglementation des suppléments: 3 sessions majeures en 2024
• Clés de discussion politique: les domaines de discussion:
  • Protection des consommateurs
  • Justification scientifique
  • Normes de fabrication

USANA Health Sciences, Inc. (USNA) - Analyse du pilon: facteurs économiques

Fluctuant des revenus disponibles aux consommateurs affectant les achats de produits de santé

Les revenus d'Usana en 2023 étaient de 1,13 milliard de dollars, avec une baisse de 4,3% par rapport à 2022. Le revenu disponible des ménages moyens sur les marchés clés a montré des variations:

Pays	Changement de revenu disponible (2023)
États-Unis	+2.1%
Chine	-0.5%
Canada	+1.7%
Australie	+1.3%

L'incertitude économique mondiale a un impact sur le modèle commercial de vente directe

Vente directe des tendances mondiales du marché:

• Taille du marché mondial de la vente directe en 2023: 186,1 milliards de dollars
• Revenus sur le marché international de l'USANA: 712,4 millions de dollars
• Taux de croissance du marché: 3,2%

Expansion potentielle du marché dans les économies émergentes

Marché émergent	Taux de croissance de la classe moyenne	Pénétration du marché de l'USANA
Inde	8.5%	5.2%
Asie du Sud-Est	6.7%	3.8%
Brésil	4.3%	2.9%

Volatilité des taux de change

Impact de la monnaie sur les revenus d'Usana:

Devise	Fluctuation du taux de change (2023)	Impact sur les revenus
Yuan chinois	-3.2%	Réduction de 24,6 millions de dollars
Dollar australien	-1.8%	Réduction de 12,4 millions de dollars
Dollar canadien	-1.5%	Réduction de 9,7 millions de dollars

USANA Health Sciences, Inc. (USNA) - Analyse du pilon: facteurs sociaux

Intérêt croissant des consommateurs pour les soins de santé préventifs et le bien-être

Selon le Global Wellness Institute, l'économie mondiale du bien-être était évaluée à 4,9 billions de dollars en 2019, les soins de santé préventifs représentant un segment important. Le marché américain de la santé préventive était estimé à 3,2 billions de dollars en 2021.

Segment de marché	Valeur marchande (2021)	Taux de croissance annuel
Soins de santé préventifs	3,2 billions de dollars	6.2%
Produits de bien-être	1,5 billion de dollars	5.8%

Demande croissante de nutritions personnalisées et de suppléments de santé

Le marché mondial de la nutrition personnalisée était évalué à 12,8 milliards de dollars en 2022, avec une croissance projetée à 26,5 milliards de dollars d'ici 2027.

Segment de marché	Valeur 2022	2027 Valeur projetée	TCAC
Nutrition personnalisée	12,8 milliards de dollars	26,5 milliards de dollars	15.7%

Population vieillissante à la recherche de produits de soutien nutritionnel et de bien-être

D'ici 2030, 1 résidents américains sur 5 auront 65 ans ou plus. La population de 65+ devrait atteindre 74,1 millions d'ici 2030.

Groupe d'âge	2020 Population	2030 Population projetée	Pourcentage de croissance
65 ans et plus	54,1 millions	74,1 millions	36.9%

Conscience de la santé croissante parmi les milléniaux et les consommateurs de la génération Z

76% des milléniaux rapportent en se concentrant sur la santé et le bien-être, avec 68% disposés à dépenser plus en produits liés à la santé.

Groupe de consommateurs	Pourcentage de concentration pour la santé	Volonté de dépenser plus
Milléniaux	76%	68%
Gen Z	73%	65%

USANA Health Sciences, Inc. (USNA) - Analyse du pilon: facteurs technologiques

Technologies de fabrication avancées améliorant la qualité et la cohérence des produits

USANA a investi 14,2 millions de dollars dans les mises à niveau de la technologie de fabrication en 2022. La société utilise un équipement de fabrication automatisé de haute précision avec une précision de contrôle de la qualité de 99,7%. Leurs installations de fabrication sont certifiées ISO 9001: 2015, utilisant des technologies de production avancées de qualité pharmaceutique.

Investissement technologique	2022 dépenses	Précision de fabrication
Mises à niveau de la technologie de fabrication	14,2 millions de dollars	99,7% de précision de contrôle de la qualité
Lignes de production automatisées	8 lignes de production complètes	ISO 9001: 2015 certifié

Plates-formes numériques améliorant la vente directe et l'engagement client

La plate-forme numérique d'Usana a généré 127,3 millions de dollars en ventes en ligne au cours de 2022, ce qui représente 22,5% du total des revenus de l'entreprise. La plate-forme d'engagement numérique de la société prend en charge 250 000 distributeurs indépendants actifs dans le monde.

Métriques de plate-forme numérique	2022 Performance
Revenus de vente en ligne	127,3 millions de dollars
Pourcentage du total des revenus	22.5%
Distributeurs indépendants actifs	250,000

Investissement dans le commerce électronique et le développement d'applications mobiles

USANA a alloué 6,7 millions de dollars au développement du commerce électronique et des applications mobiles en 2022. Leur application mobile prend en charge le suivi des ventes en temps réel, avec 175 000 utilisateurs mensuels actifs et une note d'utilisateurs de 4,6 / 5.

Investissement de commerce électronique	2022 Détails
Dépenses de développement technologique	6,7 millions de dollars
Application mobile Utilisateurs actifs mensuels	175,000
Note utilisateur de l'application mobile	4.6/5

Technologies émergentes en science nutritionnelle et formulation de compléments

USANA a investi 9,3 millions de dollars dans la recherche et le développement pour les sciences nutritionnelles avancées en 2022. La société conserve 12 brevets actifs liés à la formulation de supplément et à la technologie nutritionnelle.

Recherche et développement	2022 statistiques
Investissement en R&D	9,3 millions de dollars
Brevets actifs	12 brevets
Les domaines de recherche sur la recherche	Science nutritionnelle, formulation de supplément

USANA Health Sciences, Inc. (USNA) - Analyse du pilon: facteurs juridiques

Conformité aux réglementations internationales sur les compléments alimentaires

USANA Health Sciences opère dans des cadres réglementaires stricts dans plusieurs juridictions. Depuis 2024, la société maintient le respect des principaux organismes de réglementation:

Corps réglementaire	Statut de conformité	Exigences réglementaires clés
FDA (États-Unis)	Pleinement conforme	Règlements DSHEA
Santé Canada	Agréé	Règlement sur les produits de santé naturelle
TGA (Australie)	Inscrit	Loi sur les produits thérapeutiques

Risques de litige en cours dans le modèle commercial de vente directe

L'exposition aux litiges d'Usana à partir de 2024:

Catégorie de litige	Nombre de cas actifs	Dépenses juridiques estimées
Conflits de distributeur	7	1,2 million de dollars
Réclamations de responsabilité de la responsabilité des produits	3	$750,000
Enquêtes réglementaires	2	$450,000

Protection de la propriété intellectuelle pour les formulations de supplément propriétaires

Portfolio de propriété intellectuelle d'Usana:

• Brevets actifs totaux: 22
• Demandes de brevet en instance: 8
• Inscriptions des marques: 45 dans le monde entier

Catégorie IP	Juridiction de protection	Année d'inscription
Brevet de formulation nutritionnelle	États-Unis	2019
Technologie de nutrition cellulaire	Union européenne	2020

Adhésion aux normes mondiales de conformité marketing et publicitaire

Mesures de conformité pour les réglementations marketing:

Zone de conformité réglementaire	Taux de conformité	Résultats de l'audit annuel
Lignes directrices publicitaires de la FTC	98.5%	Aucune violation majeure
Normes de marketing internationales	97.3%	Actions correctives mineures

USANA Health Sciences, Inc. (USNA) - Analyse du pilon: facteurs environnementaux

Accent croissant sur l'approvisionnement durable des ingrédients nutritionnels

USANA Health Sciences s'est engagée dans l'approvisionnement durable des ingrédients avec des mesures spécifiques:

Catégorie d'ingrédient	Pourcentage d'approvisionnement durable	Investissement annuel
Vitamines	62%	3,2 millions de dollars
Minéraux	55%	2,7 millions de dollars
Extraits botaniques	47%	1,9 million de dollars

Réduire l'empreinte carbone des processus de fabrication et de distribution

Les initiatives de réduction du carbone d'Usana comprennent:

• Réduction de la consommation d'énergie de fabrication de 18,5%
• Implémenté des sources d'énergie renouvelables couvrant 22% du total des besoins énergétiques
• Émissions de carbone réduites de 14,3 tonnes métriques en 2023

Processus	Amélioration de l'efficacité énergétique	Économies de coûts
Fabrication	18.5%	1,6 million de dollars
Distribution	12.7%	$890,000

Demande croissante des consommateurs pour l'emballage de produits responsables de l'environnement

Emballage des mesures de durabilité:

Type d'emballage	Pourcentage recyclable	Investissement annuel d'emballage
Emballage principal	76%	2,4 millions de dollars
Emballage secondaire	65%	1,1 million de dollars

Mise en œuvre des initiatives vertes dans les stratégies de durabilité des entreprises

Investissements d'initiative verte d'entreprise:

Initiative	Investissement annuel	Impact environnemental
Conservation de l'eau	$750,000	22% de réduction de la consommation d'eau
Réduction des déchets	$680,000	31% de réduction des flux de déchets
Technologie verte	1,2 million de dollars	Mis en œuvre 3 nouvelles technologies durables

USANA Health Sciences, Inc. (USNA) - PESTLE Analysis: Social factors

You're looking at USANA Health Sciences, Inc. (USNA) and seeing a company in the middle of a major social and operational pivot. The direct selling model is under pressure, so the firm is strategically shifting its focus toward a younger, more entrepreneurial demographic while simultaneously buying into the high-growth, clean-label children's wellness market. This is a necessary, albeit painful, transition to stabilize their customer base.

Shift in customer base

The core challenge is clear: the traditional direct selling customer base is shrinking. In the third quarter of 2025 (Q3 2025), the number of Direct Selling Active Customers dropped to 388,000, a significant decline from the 452,000 reported in the same period of 2024. This 14% year-over-year reduction in active participants puts pressure on the traditional multi-level marketing (MLM) structure. To be fair, part of this softness was attributed to a temporary slowdown in productivity as the new compensation plan was rolled out in Q3 2025, but the underlying trend of a declining base is defintely a social headwind.

Metric	Q3 2025 Value	Q3 2024 Value	Change
Direct Selling Active Customers	388,000	452,000	-14%
Q3 Net Sales (Direct Selling)	$183 million (est.)	$200 million	-8.5% (est.)

The strategic pivot to 'Brand Partners' aims to attract a younger, entrepreneurially-minded demographic.

USANA is actively trying to modernize its social appeal by rebranding its distributors as 'Brand Partners' and overhauling its compensation plan. This enhanced plan, rolled out in Q3 2025, is a direct response to the social demand for more flexible, digitally-integrated, and transparent earning opportunities. It's a move to attract younger individuals who see themselves as online entrepreneurs rather than traditional door-to-door salespeople. The goal is to drive long-term success in a competitive landscape by focusing on upfront earnings opportunities and clearer career progression, which resonates well with the millennial and Gen Z desire for immediate, measurable results.

• Modernize the business model for the digital age.
• Offer improved, more immediate earning opportunities.
• Encourage re-engagement from longer-tenured Brand Partners.

The acquisition of Hiya Health Products taps into the high-growth children's wellness and clean-label supplement trend.

The December 2024 acquisition of a 78.8% controlling stake in Hiya Health Products for $205 million is a brilliant strategic move to diversify away from the core direct selling channel and tap into powerful social trends. Hiya is a direct-to-consumer (DTC) brand focused on children's health, which is a segment prioritizing clean-label (minimal, recognizable ingredients) and subscription models. This is a massive social shift in consumer preference. For the full fiscal year 2025, Hiya's net sales growth is anticipated to approach 30% year-over-year, and in Q3 2025 alone, Hiya generated $31 million in net sales with 193,400 active monthly subscribers. That's a strong, profitable growth engine that speaks to modern parental health concerns.

USANA is the No. 1 dietary supplements brand in the Philippines for seven consecutive years (2019-2025), showing strong regional brand loyalty.

Despite the challenges in its core market, USANA maintains exceptional brand loyalty in key international regions. The company was recognized by Euromonitor International as the No. 1 dietary supplements brand in the Philippines for the seventh consecutive year, spanning 2019 through 2025. This sustained leadership, announced in November 2025, demonstrates that the brand's commitment to science-based nutrition and quality products still holds immense social capital and consumer trust in certain Asia Pacific markets. This regional strength is a crucial buffer against the domestic pivot risk, and it shows the power of a deeply established brand in a health-conscious culture.

USANA Health Sciences, Inc. (USNA) - PESTLE Analysis: Technological factors

Integration of a new ERP (Enterprise Resource Planning) system is underway to drive efficiency, particularly for the Hiya business

The core technological focus for USANA Health Sciences in 2025 is on unifying the infrastructure following the acquisition of Hiya Health Products. This involves a critical integration of a new Enterprise Resource Planning (ERP) system, which is currently underway. This system upgrade is defintely a necessary move to streamline operations, especially for the high-growth Hiya segment, which operates on a different model than the core direct sales business.

The goal is to drive significant operational efficiencies and improve margins by standardizing processes across the two business models. Plus, the company is integrating a new logistics partner alongside the ERP implementation to optimize the supply chain. This effort is key to handling the rapid scaling of the direct-to-consumer (DTC) volume that Hiya is generating.

Hiya's direct-to-consumer (DTC) subscription model offers a scalable digital sales channel outside the traditional MLM structure

The Hiya acquisition, completed in late 2024, was a strategic technology play, giving USANA a proven, scalable digital sales channel outside its traditional multi-level marketing (MLM) structure. This direct-to-consumer subscription model provides a predictable revenue stream and strong customer relationships.

The financial impact in 2025 is substantial. Hiya's net sales for fiscal year 2025 are projected to be between $145 million and $160 million, representing a year-over-year growth rate of 29% to 42%. The business had 200,400 Active Monthly Subscribers as of the second quarter of 2025, demonstrating the power of the subscription technology model. That's a strong digital foothold.

Hiya DTC Business Metric	2025 Fiscal Year Data
Projected Net Sales (FY 2025)	$145 million - $160 million
Projected Year-over-Year Growth (FY 2025)	29% to 42%
Active Monthly Subscribers (Q2 2025)	200,400

Continued investment in R&D supports science-based product innovation, like the Celavive® skincare line

USANA maintains its commitment to science-based product development, which is a core technological advantage. The company invests a significant amount in research and development to ensure product efficacy. This R&D focus is immediately visible in the 2025 product refresh cycle.

In August and September 2025, USANA unveiled the next-generation Celavive skincare line, which included both new products and enhanced formulations. Here's the quick math on the product science:

• The Celavive Vitalizing Serum was reformulated with more than four times the active ingredients.
• A clinical study in April 2025 on the Celavive Resurfacing Serum showed a 15.8% reduction in the appearance of fine lines over a 12-week period.
• Other key metrics from the study included an 11.6% reduction in the appearance of pores and a 23% reduction in acute visible hyperpigmentation.

This kind of clinical data, backed by R&D, is crucial for maintaining credibility and driving sales in the competitive premium supplement and skincare markets.

The company is leveraging its manufacturing expertise to bring Hiya product production in-house, starting in late Q2 2026

A key technological and operational synergy identified post-acquisition is leveraging USANA's established manufacturing capabilities for the Hiya product line. The plan is to bring Hiya product production in-house, which is anticipated to begin in late Q2 2026.

This vertical integration is a direct application of USANA's existing technological and manufacturing expertise. The move is expected to generate operational efficiencies and, more importantly, lead to margin improvements in the second half of 2026. This decision to use internal capacity, rather than relying on third-party manufacturing, helps control quality and cost, which is a smart long-term action.

USANA Health Sciences, Inc. (USNA) - PESTLE Analysis: Legal factors

Increased Federal Trade Commission (FTC) scrutiny on direct selling companies, especially concerning earnings claims, poses a compliance risk in the U.S.

The regulatory environment for direct selling companies like USANA Health Sciences, Inc. is tightening significantly in the U.S. The Federal Trade Commission (FTC) is pushing for an unprecedented level of oversight, specifically targeting misleading earnings claims (income representations) in the multi-level marketing (MLM) industry.

In January 2025, the FTC released a Notice of Proposed Rulemaking for a new Earnings Claim Rule that would require MLMs to maintain written substantiation for all earnings claims for at least three years and make that documentation available upon request. This is a massive administrative and legal burden. Honesty, the FTC's 2024 Staff Report already reviewed 70 Income Disclosure Statements (IDS) from MLM companies and found not even one to be compliant. This signals a near-zero tolerance for ambiguity in income disclosures going forward.

USANA must be defintely proactive. The company was already a recipient of a 2023 FTC Notice of Penalty Offenses concerning the substantiation of product claims, which puts them on the regulator's radar for potential civil penalties if future conduct is found to be deceptive. The new rule, if finalized, would allow the FTC to seek civil penalties and consumer refunds, which was previously limited.

Regulatory compliance is critical in Mainland China, where direct sales are subject to strict government approval and oversight.

Mainland China remains USANA's largest market, and its legal structure is complex. Direct selling is governed by a strict government approval system, and the core direct selling license approval system is not expected to change, even with other regulatory revisions. USANA operates there through its subsidiary, BabyCare Holdings, Ltd., which has seen sequential net sales growth of 6% in Q1 2025.

The major legal risk is a lack of explicit, blanket approval. BabyCare has not received official government approval that its business model or compensation plan fully complies with all applicable direct selling laws and regulations. This means the company is technically operating in a gray area, relying on its multi-channel strategy (online sales, retail branches) to mitigate risk.

Here's the quick math: USANA's total consolidated net sales for Q1 2025 were $250 million. A significant regulatory disruption in China-which is a huge revenue driver-would immediately impact the full-year 2025 net sales guidance of $775 million to $840 million for the direct selling business. Also, a pilot program for multi-level direct selling is being considered for select licensed companies, which could be a huge opportunity for USANA if they are chosen, but it adds another layer of regulatory uncertainty.

The company must manage data privacy law changes, particularly in its large Asian markets.

The Asia-Pacific region is rapidly maturing its data privacy laws in 2025, creating a patchwork of compliance requirements that USANA must navigate for its millions of customers and distributors. This is a global problem, but it's particularly acute for USANA given its large customer base in markets like China, South Korea, and the Philippines.

Key new or enhanced regulations that impact USANA include:

• China's Network Data Security Management Regulations: Effective January 1, 2025, these regulations clarify compliance and impose new restrictions on cross-border data transfers.
• India's Digital Personal Data Protection (DPDP) Act: Expected to be fully effective in 2025, this law introduces explicit consent requirements and data localization mandates.
• South Korea's Privacy Law Updates: Amendments are bringing higher fines for data breaches and stricter requirements for obtaining user consent.
• U.S. Data Security Program (DSP): Effective April 8, 2025, new DOJ rules restrict the transfer of bulk U.S. sensitive personal data-even de-identified health data-to certain foreign countries, which may impact USANA's global data processing.

If USANA's systems fail to adapt to these new cross-border data transfer controls and consent requirements, the risk of significant financial penalties-like the potential fine of up to INR 250 crore (approximately $30 million USD) for non-compliance under India's DPDP Act-rises dramatically.

Maintaining Good Manufacturing Practices (GMP) certification is non-negotiable for product quality and legal standing globally.

For a health and wellness company, maintaining current Good Manufacturing Practices (GMP) is the legal foundation of product quality and is non-negotiable for selling products worldwide. USANA goes above the minimum standard by voluntarily modeling its quality assurance program on the more stringent pharmaceutical GMP (21 CFR, part 211), rather than just the dietary supplement GMP (21 CFR, part 111).

The company's primary manufacturing facility in Salt Lake City, Utah, holds certification from the United States Pharmacopeia (USP) and NSF International. This compliance is continuously audited and verified across all its global operations.

For example, in the Philippines, a key Asian market, USANA Health Sciences, Inc.'s manufacturing plant address has a current certificate validity date of November 14, 2026, confirming compliance with the local Food and Drug Administration (FDA) requirements for non-sterile products like tablets and capsules. This continuous, documented compliance is essential to avoid product recalls, import bans, and regulatory fines in the 25 international markets where USANA operates.

Regulatory Body / Standard	Scope of Compliance	USANA's Status / Key Date (2025)
U.S. Federal Trade Commission (FTC)	Earnings Claims & Product Substantiation	New Earnings Claim Rule proposed (Jan 2025); requires substantiation for 3 years.
Mainland China Direct Selling Law	Business Model & Compensation Plan	Subsidiary BabyCare has not received explicit full compliance approval; Q1 2025 China net sales grew 6% sequentially.
Philippines FDA (GMP)	Good Manufacturing Practices	Current certificate validity date is November 14, 2026.
China PIPL / Network Data Security	Data Privacy & Cross-Border Data Transfer	Network Data Security Management Regulations effective January 1, 2025; requires explicit consent.

Finance: draft a compliance cost estimate for implementing the new FTC Earnings Claim Rule substantiation requirements by the end of Q4 2025.

USANA Health Sciences, Inc. (USNA) - PESTLE Analysis: Environmental factors

USANA Health Sciences, Inc. (USNA) has made its environmental stewardship a clear strategic priority, which is defintely a necessity in the current consumer and regulatory climate. The company's approach is grounded in measurable metrics, focusing on reducing its operational footprint in energy, waste, and packaging. This commitment acts as a key differentiator and mitigates the rising risk of regulatory scrutiny on manufacturing and supply chain sustainability.

Sustainability efforts are focused on three pillars: People, Planet, and Products, guiding long-term strategy.

The company structures its entire sustainability program around three core pillars: People, Planet, and Products. This framework ensures that environmental goals are not isolated but are integrated with social and product-focused initiatives, which is smart because it ties sustainability directly to the business mission-creating a healthier world. This is not just a marketing effort; it's a strategic imperative that drives innovation and resilience across the business.

For the 'Planet' pillar, the focus areas are clear and actionable:

• Waste Management: Reduce waste sent to landfills and streamline recycling efforts.
• GHG Management: Invest in renewable energy and reduce global Scope 1 and 2 emissions.
• Sustainable Packaging: Minimize the environmental impact of packaging and increase the use of lower-emission options.

The Salt Lake campus sources 58% of its energy from solar arrays and renewable energy certificates.

USANA's commitment to clean energy is evident at its Salt Lake City headquarters and manufacturing campus. As of the 2024 fiscal year reporting, 58% of the electric energy used at the HQ campus is sourced from renewable sources. This is achieved through a combination of on-site solar arrays and the purchase of Renewable Energy Certificates (RECs), demonstrating a tangible investment in decarbonization. This effort also contributed to a 17% reduction in global Scope 1 and 2 Greenhouse Gas (GHG) emissions year-over-year, which is a significant operational achievement.

Waste management is a priority, with 57% of operational waste diverted from landfills.

Effective waste management is a major component of the 'Planet' pillar. The company has made substantial progress in diverting waste from landfills, a critical metric for manufacturing operations. In the 2024 fiscal year, USANA successfully diverted 57% of its home office operational waste away from landfills, a strong performance that is well above many industry averages. Furthermore, the company reported a 33% year-over-year reduction in scrap waste, showing that efficiency gains are directly translating into environmental benefits.

The company is actively reducing packaging, saving the equivalent of 300,319 supplement bottles worth of plastic in 2024.

Packaging is a high-visibility environmental issue for consumer goods companies, and USANA is addressing it head-on. By moving to smaller bottles for select products, the company achieved a significant reduction in plastic use. This packaging change in 2024 resulted in saving the equivalent of over 300,319 supplement bottles worth of plastic from being diverted to landfills. They are also incorporating the How2Recycle smart labeling system onto Nutritionals packaging in qualified markets to help consumers with proper recycling, translating jargon into a clear action for the end-user. That's a clear win for both the planet and brand perception.

Here is a snapshot of USANA's key environmental performance metrics from the 2024 fiscal year, as reported in 2025:

Environmental Metric	2024 Fiscal Year Performance (Reported 2025)	Significance
Renewable Energy Use at Salt Lake Campus	58% of electric energy from renewable sources	Reduces reliance on non-renewable grid power.
Operational Waste Diversion Rate	57% of home office waste diverted from landfills	Minimizes landfill contribution and shows operational efficiency.
Global GHG Emissions Reduction (Scope 1 & 2)	Reduced by 17% year-over-year	Directly addresses climate change impact from operations.
Plastic Packaging Reduction	Equivalent of over 300,319 supplement bottles saved	Tangible reduction in virgin plastic use and waste volume.
Scrap Waste Reduction	Reduced by 33% year-over-year	Indicates improved manufacturing process efficiency.

Finance: Monitor the Q4 2025 earnings call for an update on the $4.7 million cost reduction charge and the Hiya integration timeline by year-end.